Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Laprophan Raises $223 Million in Africa's Largest Pharma IPO
Laprophan raised 2.22 billion dirhams ($223 million) in an initial public offering on the Casablanca stock exchange, the largest flotation by an African pharmaceutical company. The Moroccan firm sold 6.52 million existing and new shares at 341…
Avalyn Pharma: The Tolerability Budget Is The Real Battleground In Pulmonary Fibrosis
Avalyn Pharma offers lung-directed delivery of proven antifibrotics, potentially preserving tolerability as IPF and PPF regimens incorporate additional systemic agents. AP01 targets PPF label expansion, while AP02 and combination candidate AP03…
Johnson Winter Slattery guides on acquisition of women's health specialist pharma company
The acquisition will boost the buyers' position within the women's health sector in Europe and globally. Australian law firm Johnson Winter Slattery has advised pharmaceutical manufacturer Gedeon Richter on its acquisition of Mayne Pharma Group via…
Rhythm Pharma: Is AstraZeneca/Eli Lilly's Bidding War For Real? Don't Rule It Out
I maintain a 'Hold' on Rhythm Pharmaceuticals, Inc.: takeover upside is credible, but standalone valuation and an uncertain deal make risk/reward unpersuasive. Reported bids include AstraZeneca's $124 per share and a rumored Lilly proposal around…
Pharma leaders rate ability to act on diagnostic insights just 5.2/10, Diaceutics survey finds
Pharmaceutical companies are struggling to translate diagnostic intelligence into coordinated action that helps eligible patients reach appropriate treatment, according to new research from intelligence and engagement company, Diaceutics. The…
Pharmalittle: We're reading about a Merck AI deal, China and the pharma supply chain, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they have finished keeping…
Piramal Pharma acquisition: Company to buy remaining 26% stake in Yapan Bio
Updated - November 19, 2026 at 09:36 AM. Piramal Pharma Limited said it would acquire the remaining 26 per cent equity stake in Yapan Bio Private Limited, a subsidiary of the company, from its existing shareholders. The administrative committee…
365,074 Royalty Pharma PLC $RPRX Shares Sold by Aberdeen Group plc
Aberdeen Group plc trimmed its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 63.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 213,127 shares of the…
Zurich University Hospital performs brain surgery using a hologram
The precise placement of what is known as an external ventricular catheter in a patient's brain has, until now, been a major challenge, the Zurich University Hospital stated on Thursday. The thin tube must be inserted into a ventricle of the brain…
WEF role 'option' for Lagarde after leaving ECB
“It's one of the options,” she said at the New York Times DealBook Summit. “But for the moment, I'm the president of the European Central Bank, and will be so until Febuary 7. And I'm not going to entertain any sort of…
UBS to offshore hundreds of roles to India
The offshoring push is part of a long-term strategy plan to move roles away from higher-cost European locations, according to people familiar with the matter. UBS's group functions include finance, operations, risk control, compliance, legal and…
Ascendis Pharma A/S (NASDAQ:ASND) EVP Sells 20,000 Shares of Stock
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) EVP Anni Lotte Kirstine Pedersen sold 20,000 shares of the stock in a transaction on Tuesday, November 17th. The shares were sold at an average price of $263.89, for a total value of…
Swiss exports pick up in October
Once again, it was the chemicals and pharmaceuticals sector that drove international sales, while the jewellery sector saw a decline. Exports surged by 6.3% month-on-month and in nominal terms (unadjusted for inflation) to CHF24.7 billion ($29.3…
Royalty Pharma (NASDAQ:RPRX) EVP Christopher Hite Sells 100,000 Shares of Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) EVP Christopher Hite sold 100,000 shares of Royalty Pharma stock in a transaction dated Tuesday, November 17th. The stock was sold at an average price of $68.15, for a total value of $6,815,000.00.
Royalty Pharma (NASDAQ:RPRX) CFO Terrance Coyne Sells 232,536 Shares of Company Stock
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) CFO Terrance Coyne sold 232,536 shares of the stock in a transaction on Monday, November 16th. The stock was sold at an average price of $68.87, for a total value of $16,014,754.32. The transaction…
Receive a Daily briefing on Pharma Industry News
Get Started